Disseminated Intravascular Coagulation (DIC) |
- Diffuse bleeding from multiple sites (e.g., gums, venipuncture sites, GI tract).
- Petechiae, ecchymoses, and signs of thrombosis (e.g., gangrene, organ dysfunction).
- Often associated with sepsis, trauma, malignancy, or obstetric complications.
|
- Prolonged PT, aPTT, and elevated D-dimer.
- Thrombocytopenia and decreased fibrinogen levels.
- Peripheral blood smear may show schistocytes (fragmented RBCs).
|
- Treat the underlying cause (e.g., antibiotics for sepsis, delivery for obstetric causes).
- Supportive care with blood products (e.g., platelets, fresh frozen plasma, cryoprecipitate).
- Heparin may be used in cases with predominant thrombosis.
- Monitoring of coagulation parameters and organ function.
|
Thrombotic Thrombocytopenic Purpura (TTP) |
- Pentad: Fever, neurological symptoms, renal impairment, microangiopathic hemolytic anaemia, and thrombocytopenia.
- Signs of anaemia (fatigue, pallor) and bleeding (petechiae, bruising).
- Possible confusion, seizures, or stroke-like symptoms.
|
- Severe thrombocytopenia and microangiopathic hemolytic anaemia (schistocytes on smear).
- Elevated LDH and indirect bilirubin, decreased haptoglobin.
- Normal PT and aPTT (unlike DIC).
|
- Plasma exchange (plasmapheresis) is the treatment of choice.
- Corticosteroids and rituximab may be used as adjunctive therapy.
- Avoid platelet transfusions unless there is life-threatening bleeding.
- Monitor for complications such as renal failure and neurological deficits.
|
Heparin-Induced Thrombocytopenia (HIT) |
- Thrombocytopenia occurring 5-10 days after heparin exposure.
- Thrombosis in arteries or veins, leading to complications such as DVT, PE, or stroke.
- Possible skin necrosis at injection sites.
|
- Platelet count typically drops by more than 50% from baseline.
- Positive HIT antibody (ELISA) and serotonin release assay (SRA).
- Doppler ultrasound if DVT is suspected.
|
- Immediate discontinuation of all heparin products.
- Initiate alternative anticoagulation with a direct thrombin inhibitor (e.g., argatroban, bivalirudin).
- Avoid warfarin until platelet count has recovered, and overlap with non-heparin anticoagulant when starting.
- Monitor for thrombotic events and complications.
|
Acute Haemolytic Transfusion Reaction |
- Fever, chills, and hypotension shortly after transfusion.
- Flank pain, haemoglobinuria, and signs of renal failure.
- Symptoms of shock, including tachycardia and dyspnoea.
|
- Direct Coombs test (positive for IgG or C3 on red cells).
- Serum free haemoglobin and LDH elevated, haptoglobin decreased.
- Urinalysis showing haemoglobinuria.
|
- Immediate cessation of the transfusion.
- Supportive care with IV fluids to maintain renal perfusion.
- Diuretics (e.g., furosemide) to promote urine output and prevent renal failure.
- Monitor for DIC and organ dysfunction.
|
Acute Leukaemia with Tumour Lysis Syndrome |
- Fever, fatigue, pallor, and bleeding or bruising.
- Bone pain, hepatosplenomegaly, and lymphadenopathy.
- Signs of tumour lysis syndrome: hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.
|
- Complete blood count showing leukocytosis or pancytopenia.
- Peripheral blood smear may show blasts.
- Electrolytes, renal function tests, and uric acid levels to assess for tumour lysis syndrome.
|
- IV hydration and allopurinol or rasburicase to prevent or treat tumour lysis syndrome.
- Initiation of chemotherapy under close monitoring.
- Correction of electrolyte imbalances and management of renal failure if present.
- Close monitoring in an ICU setting for severe cases.
|
Severe Thrombocytopenia |
- Spontaneous bleeding (e.g., gums, nose, GI tract), petechiae, and bruising.
- Platelet count <10,000-20,000/µL is particularly concerning.
- Possible intracranial haemorrhage in very severe cases.
|
- Complete blood count showing severe thrombocytopenia.
- Peripheral blood smear to rule out platelet clumping or pseudothrombocytopenia.
- Bone marrow biopsy if the etiology is unclear or if there is suspicion of bone marrow failure.
|
- Platelet transfusions for active bleeding or very low platelet counts.
- Treatment of the underlying cause (e.g., immunosuppression for ITP, cessation of offending drugs).
- Avoidance of anticoagulants and antiplatelet agents.
- Monitoring for signs of bleeding, especially in critical areas such as the brain.
|
Massive Pulmonary Embolism with Hemodynamic Instability |
- Sudden onset of shortness of breath, pleuritic chest pain, and syncope.
- Tachycardia, hypotension, and signs of shock.
- Signs of right heart strain (e.g., jugular venous distension, right ventricular heave).
|
- CT pulmonary angiography showing large filling defects in the pulmonary arteries.
- ECG may show right heart strain (e.g., S1Q3T3 pattern, right bundle branch block).
- ABG may show hypoxemia and respiratory alkalosis.
|
- Immediate anticoagulation with IV heparin.
- Consider thrombolytic therapy (e.g., alteplase) if hemodynamic instability is present.
- IV fluids and vasopressors to support blood pressure.
- Embolectomy may be required if thrombolysis is contraindicated or ineffective.
|
Acute Sickle Cell Crisis |
- Severe pain, typically in the bones, chest, or abdomen.
- Possible fever, swelling, and signs of anaemia (e.g., pallor, fatigue).
- Complications such as acute chest syndrome (cough, hypoxia), stroke, or splenic sequestration.
|
- Complete blood count showing anaemia and possibly increased reticulocytes.
- Peripheral blood smear showing sickle-shaped cells.
- Chest X-ray if acute chest syndrome is suspected.
|
- IV fluids and pain management with opioids.
- Oxygen therapy for hypoxia.
- Antibiotics if infection is suspected (e.g., for fever or acute chest syndrome).
- Blood transfusion may be needed for severe anaemia or acute chest syndrome.
|
Hyperviscosity Syndrome |
- Visual disturbances, headache, dizziness, and altered mental status.
- Possible bleeding, especially mucosal or retinal haemorrhages.
- Commonly associated with multiple myeloma, Waldenström's macroglobulinemia, or polycythemia vera.
|
- Serum viscosity measurement (elevated levels).
- Complete blood count showing increased hematocrit or abnormal proteins.
- Serum protein electrophoresis if monoclonal gammopathy is suspected.
|
- Plasmapheresis to remove excess proteins or red cells.
- IV fluids to reduce blood viscosity.
- Treat the underlying cause (e.g., chemotherapy for multiple myeloma).
- Monitoring for thrombotic or hemorrhagic complications.
|